Chronic Plaque Psoriasis

Immunology·MeSH: Psoriasis

6 drugs in development·3 companies·7 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
abrilada	PFIZER INC (PFE)

Phase 3(5)

Drug	Company
adalimumab	GT Biopharma, Inc. (GTBP)
bimekizumab	Cue Biopharma, Inc. (CUE)
bimekizumab	GT Biopharma, Inc. (GTBP)
secukinumab	GT Biopharma, Inc. (GTBP)
ustekinumab	GT Biopharma, Inc. (GTBP)

Compare drugs

abrilada vs adalimumab abrilada vs bimekizumab abrilada vs secukinumab

Frequently asked questions

How many drugs are in development for Chronic Plaque Psoriasis?

BioSniper tracks 6 drugs in development for Chronic Plaque Psoriasis across 3 companies.

How many clinical trials target Chronic Plaque Psoriasis?

There are 7 clinical trials targeting Chronic Plaque Psoriasis tracked by BioSniper.

Deep-dive into Chronic Plaque Psoriasis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Chronic Plaque Psoriasis — Drugs in Development & Clinical Trials | BioSniper